Tag Archives: Opioids

federal register • 28 december 2020

Posted on by

CMS has published in the federal register:

  • A Final Rule and Interim Final Rule for the Medicare Program:
    1. CY 2021 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies;
    2. Medicare Shared Savings Program Requirements;
    3. Medicaid Promoting Interoperability Program Requirements for Eligible Professionals;
    4. Quality Payment Program;
    5. Coverage of Opioid Use Disorder Services Furnished by Opioid Treatment Programs;
    6. Medicare Enrollment of Opioid Treatment Programs;
    7. Electronic Prescribing for Controlled Substances for a Covered Part D Drug;
    8. Payment for Office/Outpatient Evaluation and Management Services;
    9. Hospital IQR Program;
    10. Establish New Code Categories;
    11. Medicare Diabetes Prevention Program (MDPP) Expanded Model Emergency Policy;
    12. Coding and Payment for Virtual Check-in Services Interim Final Rule Policy;
    13. Coding and Payment for Personal Protective Equipment (PPE) Interim Final Rule Policy;
    14. Regulatory Revisions in Response to the Public Health Emergency (PHE) for COVID-19; and
    15. Finalization of Certain Provisions from the March 31st, May 8th and September 2nd Interim Final Rules in Response to the PHE for COVID-19

federal register • 23 november 2018

Posted on by

CMS has published in the federal register:

  • A Final Rule for the Medicare Program:
    1. Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2019;
    2. Medicare Shared Savings Program Requirements;
    3. Quality Payment Program;
    4. Medicaid Promoting Interoperability Program;
    5. Quality Payment Program-Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS Payment Year;
    6. Provisions From the Medicare Shared Savings Program-Accountable Care Organizations-Pathways to Success; and
    7. Expanding the Use of Telehealth Services for the Treatment of Opioid Use Disorder Under the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act